We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
China has agreed to designate fentanyl as a controlled substance, the Trump Administration announced on Saturday. Analysts told The New York Times the announcement will have little direct impact on the opioid crisis.
More than three million U.S. high school students—20.8 percent—use e-cigarettes, according to a new report by the Centers for Disease Control and Prevention.
Naloxone maker Kaleo exploited the opioid crisis by increasing the price of its drug EVZIO by more than 600 percent, according to a Senate subcommittee report.
The e-cigarette company Juul Labs announced this week it will stop selling most of its flavored e-cigarette pods in retail stores, The New York Times reports. The company will also shut down its social media accounts.
The United States has the highest rate of drug-related deaths among a group of 13 developed nations, according to a study published in the Annals of Internal Medicine.
A new study finds many pharmacies in California don’t offer the opioid overdose antidote naloxone without a prescription, even though state law has allowed pharmacists to furnish naloxone without a physician’s prescription since 2016.
A new report from the Drug Enforcement Administration finds controlled prescription drugs, including opioids, are responsible for the largest number of overdose deaths of any illicit drug class since 2001.
A Philadelphia hospital is reporting a spike in the number of patients who are being treated in the emergency room for overdoses from crack cocaine laced with fentanyl. Experts say fentanyl is being mixed with a number of drugs, including heroin, cocaine and ketamine.
The tobacco company Altria announced it is pulling its MarkTen and Green Smoke pod-style e-cigarette devices from the market, according to The Wall Street Journal.
A new opioid, Dsuvia, that is far more potent than fentanyl and 500 times stronger than morphine is nearing approval by the U.S. Food and Drug Administration, according to MarketWatch.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.